Circulation Journal · 2006 · 18 citations · 9 references
MedicineCardiologyPharmacotherapyCardiovascular PharmacotherapyClinical CardiologyInterventional CardiologyAcute Coronary SyndromesAntiplatelet TherapyAntithrombotic TherapyCoronary Artery DiseasePercutaneous Coronary InterventionThrombosisAntiplatelet Therapy After Percutaneous Coronary InterventionAntithrombotic Therapy After Stent ImplantationCoronary StentingIn-stent ThrombosisMyocardial Infarction Pharmacotherapy
BACKGROUND: The incidence of subacute stent thrombosis (SAT) within 30 days after stenting with a sirolimus-eluting stent (Cypher) for acute myocardial infarction (AMI) was retrospectively compared to that with bare-metal stents (BMS). METHODS AND RESULTS: Among 559 lesions in 558 consecutive AMI from April 2003 to February 2006, the incidence of documented SAT after Cypher implantation (2/276 lesions, 0.72%) was almost the same as for BMS (2 cases, 0.71%). Aspirin (81-100 mg/day) plus ticlopidine (200 mg/day) were administered continuously after admission in all 4 cases. CONCLUSION: Documented SAT did not increase after stenting with Cypher for AMI under aspirin plus ticlopidine.
9
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
Eugène McFadden, Eugenio Stabile, Evelyn Regar et al. · The Lancet · 2004 · 1.4K citations
Medicine, Cardiology, Pharmacology +16
Stent Thrombosis in the Modern Era
Donald E. Cutlip, Donald S. Baim, Kalon K.L. Ho et al. · Circulation · 2001 · 852 citations · Full text
Issam Moussa, Carlo Di Mario, Bernhard Reimers et al. · Journal of the American College of Cardiology · 1997 · 296 citations · Full text
Medicine, Cardiology, Surgery +16